Related references
Note: Only part of the references are listed.Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
Pascal Vranckx et al.
AMERICAN HEART JOURNAL (2018)
Standardized End Point Definitions for Coronary Intervention Trials
Hector M. Garcia-Garcia et al.
EUROPEAN HEART JOURNAL (2018)
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial
Anoop S. V. Shah et al.
LANCET (2018)
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials
Owen Faris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Large Pharmaceutical Company Perspective
Michael Rosenblatt
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Key cost drivers of pharmaceutical clinical trials in the United States
Aylin Sertkaya et al.
CLINICAL TRIALS (2016)
Pragmatic Trials
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Statement on matching language to the type of evidence used in describing observational studies vs. randomized trials
Christopher P. Cannon
EUROPEAN HEART JOURNAL (2013)
Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction
Ole Frobert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Full Coverage for Preventive Medications after Myocardial Infarction
Niteesh K. Choudhry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Share Paper
